Clinical Trial Update: Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes [Phase 4]

View source ↗

Summary

The Phase 4 pilot study of exenatide pharmacokinetics and pharmacodynamics in gestational diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Georgetown University | Conditions: Gestational Diabetes | Phase 4 | Status: WITHDRAWN